Time We Know News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Do We All Have Alzheimer’s? Drug Makers Might Want You to Think So July 30, 2021 From The Baltimore Sun: “This month, the Food and Drug Administration changed the label for the recently approved Alzheimer’s treatment aducanumab — sold under the brand name ‘Aduhelm’ — to specify that the controversial drug made by U.S. biotech company Biogen should be used only by patients with mild dementia or mild cognitive impairment. This should be no bar to widespread use, however, as recent efforts indicate that Biogen may be trying to persuade adults who occasionally misplace their keys that they not only have Mild Cognitive Impairment (MCI), but that MCI is an early form of

United statesDrug administrationBaltimore sunFrom the baltimore sunMild cognitive impairmentTime we knowஒன்றுபட்டது மாநிலங்களில்பால்டிமோர் சூரியன்இருந்து தி பால்டிமோர் சூரியன்லேசான அறிவாற்றல் குறைபாடு